Research work · 2006

Voriconazole Therapeutic Drug Monitoring

Jeannina A. Smith, Nasia Safdar, Valerie Knasinski, William D. Simmons, Sujata M. Bhavnani, Paul G. Ambrose, David R. Andes

Antimicrobial Agents and Chemotherapy

Abstract

We report on 28 patients who underwent voriconazole monitoring because of disease progression or toxicity. A relationship (P<0.025) between disease progression and drug concentration was detected. Favorable responses were observed in 10/10 patients with concentrations above 2.05 microg/ml, while disease progressed in 44% (n=18) of patients with concentrations below 2.05 microg/ml.

Read free full text

DOI: 10.1128/aac.50.4.1570-1572.2006